These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18380636)

  • 1. Gaussian process metamodeling in Bayesian value of information analysis: a case of the complex health economic model for breast cancer screening.
    Rojnik K; Naversnik K
    Value Health; 2008; 11(2):240-50. PubMed ID: 18380636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia.
    Rojnik K; Naversnik K; Mateović-Rojnik T; Primiczakelj M
    Value Health; 2008; 11(2):139-48. PubMed ID: 18380626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.
    Tappenden P; Chilcott JB; Eggington S; Oakley J; McCabe C
    Health Technol Assess; 2004 Jun; 8(27):iii, 1-78. PubMed ID: 15215017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research.
    Oostenbrink JB; Al MJ; Oppe M; Rutten-van Mölken MP
    Value Health; 2008 Dec; 11(7):1070-80. PubMed ID: 19602213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
    Hoomans T; Fenwick EA; Palmer S; Claxton K
    Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertainty in decision-making: value of additional information in the cost-effectiveness of lifestyle intervention in overweight and obese people.
    Galani C; Al M; Schneider H; Rutten FF
    Value Health; 2008; 11(3):424-34. PubMed ID: 18179675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of information analysis from a societal perspective: a case study in prevention of major depression.
    Mohseninejad L; van Baal PH; van den Berg M; Buskens E; Feenstra T
    Value Health; 2013 Jun; 16(4):490-7. PubMed ID: 23796282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness and Value-of-Information Analysis Using Machine Learning-Based Metamodeling: A Case of Hepatitis C Treatment.
    McCandlish JA; Ayer T; Chhatwal J
    Med Decis Making; 2023 Jan; 43(1):68-77. PubMed ID: 36113098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.
    Favato G; Baio G; Capone A; Marcellusi A; Saverio Mennini F
    Clin Ther; 2013 Jul; 35(7):904-14. PubMed ID: 23806328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation sample sizes for Monte Carlo partial EVPI calculations.
    Oakley JE; Brennan A; Tappenden P; Chilcott J
    J Health Econ; 2010 May; 29(3):468-77. PubMed ID: 20378190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.
    Sadatsafavi M; Marra C; Bryan S
    Health Econ; 2013 Jul; 22(7):877-82. PubMed ID: 22933363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach for sample size calculation in cost-effectiveness studies based on value of information.
    Bader C; Cossin S; Maillard A; Bénard A
    BMC Med Res Methodol; 2018 Oct; 18(1):113. PubMed ID: 30348087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).
    Barton GR; Briggs AH; Fenwick EA
    Value Health; 2008; 11(5):886-97. PubMed ID: 18489513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.